RISE Act of 2021

H.R. 1466 - Safe RESEARCH Act H.R. 1827 - Pausing Enhanced Pandemic Pathogen Research Act of 2023 H.R. 4421 - Preparing for All Hazards and Pathogen Reauthorization Act H.R. 4002 - Relieving Economic Strain to Enhance American Resilience and Competitiveness in Higher Education and Research Act S. 289 - Genomics Data Security Act H.R. 2670 - National Defense Authorization Act for FY24 (NDAA) S. 2226 - National Defense Authorization Act for FY24 (NDAA) S. 2333 - Pandemic and All Hazards Preparedness Reauthorization Act S. ____ - CHIPS 2.0 S. 1351 - Safeguarding American Innovation Act (117th Congress) -- regarding research-related funding and policy issues affecting higher education institutions and their faculty and students.

Client expense: $82,292 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1466 - Safe RESEARCH Act H.R. 1827 - Pausing Enhanced Pandemic Pathogen Research Act of 2023 H.R. 4421 - Preparing for All Hazards and Pathogen Reauthorization Act H.R. 2670 - National Defense Authorization Act for FY24 (NDAA) S. 289 - Genomics Data Security Act S. 2226 - National Defense Authorization Act for FY24 (NDAA) S. 2333 - Pandemic and All Hazards Preparedness Reauthorization Act S. ____ - CHIPS 2.0 S. 1351 - Safeguarding American Innovation Act (117th Congress) -- regarding research-related funding and policy issues affecting higher education institutions and their faculty and students.

Client expense: $34,849 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 869/ S. 289: Research Investment to Spark the Economy (RISE) Act H.R. 8262, Interior and Environment Appropriations, 2023 H.R. 8295: Labor, Health, and Human Services, 2023 H.R. 8256/: Commerce, State, Justice, 2023 H.R. 8255: Energy-Water, 2022

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries. Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act Support legislation aimed at accelerating medical research and patient access to novel therapeutics H.R. 6000 the Cures 2.0 Act

Client expense: $326,542 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS H.R. 5030: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS H.R. 5566: FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT OF 2021; ALL PROVISIONS H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS S. 2706: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS S. 3799: PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT; PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES GENERAL DISCUSSIONS REGARDING THE 2023 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2023 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

P.L. 111-148 Affordable Care Act, modifications Prior authorization utilization policies Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Medicare Physician Payment Reform Issues Medicare sequestration cuts Drug Pricing and Shortages Issues Medicare Part B Drug Price Issues Expansion of Telehealth Services Vision Research Funding Implementation of No Surprise Act HR 3173/S 3018, the Improving Seniors' Timely Access to Care Act HR 2163/S 464, Safe Step Act HR 1916/S 754, Ensuring Lasting Smiles Act Medicare Coverage for Low Vision Devices HR 4187, the Medicare Vision Act HR 869/S 289, Research Investment to Spark the Economy (RISE) Act HR 366, Protecting Access to Post-COVID 19 Telehealth Act HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021 HR 3353, the Contact Lens Prescription Verification Modernization Act HR4122, Resident Education Deferred Interest (REDI) Act HR 5376, the Build Back Better Act HR 6000, Cures 2.0 Act S. 4333, the CLEAR Act S. 4348, Food and Drug Administration Safety & Landmark Advancements (FDASLA) Act

Client expense: $406,636 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Public health program funding Federal research funding Emergency funding for COVID therapeutics Research Investment to Spark the Economy (RISE) Act (H.R. 869/S. 289) Cures 2.0 Act (H.R. 6000) Advanced Research Projects Agency for Health (ARPA-H) FY 2023 NIH funding FY 2023 AHRQ funding FY 2023 CDC funding FY 2023 funding for CDC Sickle Cell Data Collection program FY 2023 funding for HRSA Sickle Cell Disease Treatment Demonstration program and Sickle Cell Disease Newborn Screening program Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023 (H.R. 8295/S. 4659) FY2023 Further Continuing Appropriations Act (through 12/23/2022) (H.R. 1437) FY2023 Further Additional Continuing Appropriations Act (through 12/30/2022) (H.R. 4373) FY2023 Consolidated Appropriations Act (H.R. 2617)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), President of the U.S., SENATE

Sickle cell disease/trait issues Hematology/oncology treatment issues Hematology/oncology drug research and approval issues General hematology public health and research issues Emergency funding for COVID therapeutics Research Investment to Spark the Economy (RISE) Act (H.R. 869/S. 289) Open access policy for peer reviewed research journals Issues impacting blood supply shortages/safety Issues related to convalescent plasma Issues impacting delivery of bone marrow, peripheral blood, and cord blood Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations COVID-19 vaccination policies/prioritization Clinical trials regulations and coverage Issues related to diversity, equity, and inclusion (DEI) in hematology research, practice, and training Cures 2.0 Act (H.R. 6000) Advanced Research Projects Agency for Health (ARPA-H) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706 / H.R. 5030) Meaningful Access to Federal Health Plan Claims Data Act (H.R. 5394) Health Equity and Accountability Act (H.R. 7585) Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 4128/S. 2209) Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act (S. 4348)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), President of the U.S., SENATE

H.R. 847/S. 224, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1816, Information Transparency & Personal Data Control Act H.R. 2501, Spectrum Coordination Act H.R. 2668/S. 1494, Consumer Protection and Recovery Act H.R. 3684, Infrastructure Investment and Jobs Act H.R. 3711, Safely Ensuring Lives Future Deployment and Research in Vehicle Evolution (SELF DRIVE) Act H.R. 3816, American Choice and Innovation Online Act H.R. 3826, Platform Competition and Opportunity Act of 2021 H.R. 3849, Augmenting Compatibility and Competition by Enabling Service Switching (ACCESS) Act of 2021 H.R. 4258, Improving Digital Identity Act of 2021 H.R. 4346, CHIPS and Science Act H.R. 4350, National Defense Authorization Act for Fiscal Year 2022 H.R. 4609, National Institute of Standards and Technology for the Future Act of 2021 H.R. 5315, Drone Infrastructure Inspection Grant Act H.R. 5376, Inflation Reduction Act of 2022 H.R. 6416, Banning Surveillance Advertising Act of 2022 H.R. 6580/S. 3572, Algorithmic Accountability Act of 2022 H.R. 6796, Digital Services Oversight and Safety Act of 2022 H.R. 7900, National Defense Authorization Act for Fiscal Year 2023 H.R. 8152, American Data Privacy and Protection Act H.R. 8256/S. 4664, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 H.R. 9463, Satellite And Telecommunications (SAT) Streamlining Act of 2022 S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 919, Data Care Act of 2021 S. 1260, United States Innovation and Competition Act of 2021 S. 1494, Consumer Data Privacy and Security Act of 2021 S. 1957, State and Local Digital Service Act of 2021 S. 2710, Open App Markets Act S. 2992, American Innovation and Choice Online Act S. 3014, Next Generation Telecommunications Act S. 3035, Government Ownership and Oversight of Data in Artificial Intelligence (GOOD AI) Act of 2021 S. 3290, National MEP Supply Chain Database Act of 2021 S. 3330, Deceptive Experiences To Online Users Reduction (DETOUR) Act S. 3410, The Consumer Protection and Due Process Act S. 3663, Kids Online Safety Act S. 3890, Improving Intergovernmental Cooperation and Reducing Duplication Act of 2022 S. 4145, Consumer Protection Remedies Act of 2022 S. 4767, Proper Leadership to Align Networks for Broadband Act (PLAN) for Broadband Act Draft legislation titled FTC Procedural Reform Potential legislation related to the regulation of facial recognition technology Draft legislation on platform transparency Draft legislation on improvements to the Paperwork Reduction Act Draft legislation around collection and sharing of government data Request for Comments on a Draft Memorandum to the Heads of Executive Departments and Agencies, Guidance for Regulation of Artificial Intelligence Applications (85 Fed. Reg. 1,825, January 13, 2020) Advanced Notice of Proposed Rulemaking, Federal Trade Commission; Deceptive or Unfair Earnings Claims (87 Fed. Reg. 13,951-13,958, March 11, 2022) Proposed Rule, Federal Trade Commission; Advance Notice of Proposed Rulemaking for Trade Regulation Rule on Commercial Surveillance and Data Security (87 Fed. Reg. 51,273-51,299, August 22, 2022) Advance Notice of Proposed Rulemaking; Extension of Comment Period, Federal Trade Commission; Trade Regulation Rule on Commercial Surveillance and Data Security (87 Fed. Reg. 63,738-63,739, October 20, 2022) Notice of Inquiry, Federal Communications Commission; Space Innovation; Facilitating Capabilities for In-space Services, Assembly, and Manufacturing (ISAM) (87 Fed. Reg. 56,365-56,372, September 14, 2022) Public Notice, Federal Communications Commission; Amendment of Section 15.255 of the Commissions Rules (ET Docket No. 21-264, June 22, 2021) Request for Information, National Institutes of Standards and Technology, Department of Commerce; Implementation of the CHIPS Incentives Program (87 Fed. Reg. 61570-61573, October 12, 2022) Various issues relating to expanding access to high speed broadband internet service; broadband infrastructure and deployment; broadband permitting reform; nominations at Federal Trade Commission (FTC), Federal Communications Commission (FCC), and Office of Science and Technology Policy (OSTP); broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); funding for implementation of the CHIPS for America Act, enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); implementation of the National Artificial Intelligence Act, enacted as part of the FY2021 National Defense Authorization Act (P.L. 116-283); implementation of the Drivers Privacy Protection Act (P.L. 103-322); implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58); implementation of the Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science Act, (P.L. 117-167); appropriating funding for the Public Wireless Supply Chain Fund and the Multilateral Telecommunications Security Fund; increased technology modernization funding for FY22; FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; Executive Order 13984, Taking Additional Steps to Address the National Emergency with Respect to Significant Malicious Cyber-Enabled Activities; Executive Order 14017, Executive Order on America's Supply Chains; FTC hearings on Competition and Consumer Protection; Consumer Cybersecurity Labeling Pilots; Feedback to NIST on AI Risk Management: Future of the FCC Universal Service Fund; Federal Trade Commission (FTC) franchise rule and earnings rule; FTC enforcement; FTC section 13(b) and 19(b) enforcement; potential Executive Order on identity theft; potential childrens privacy legislation in omnibus spending bill; Technology Modernization Fund in Financial Services and General Government proposed appropriations legislation; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); draft National Institute of Standards and Technology (NIST) guidance on Federal Internet of Things Device Cybersecurity; Security Criteria for Internet of Things (IoT) Devices; Draft Consumer Software Labeling Criteria; artificial intelligence regulation, standards, research and development; House Select Committee on Modernization; the Administrations Counter Unmanned Aircraft Systems (UAS) Action Plan; use of third-party messaging apps by corporate employees; request for information, National Institute of Standards and Technology, artificial intelligence risk; management framework second draft (August 18, 2022); Office of Science and Technology Policies Blueprint for an AI Bill of Rights; Buy America provisions in the Infrastructure Investment and Jobs Act (P.L. 117-58); Freedom of Information requests: Department of Education, Department of Health and Human Services, Consumer Financial Protection Bureau, National Telecommunications and Information Administration, Federal Trade Commission, and Equal Employment Opportunity Commission

Client expense: $20,990,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Aeronautics & Space Administration (NASA), Natl Highway Traffic Safety Administration (NHTSA), Natl Science Foundation (NSF), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA)

Issue: Support reducing administrative and regulatory burden on scientists and research institutions. H.R. 4521, America COMPETES Act of 2022 S.1260, United States Innovation and Competition Act of 2021 P.L. 117-167, Supreme Court Funding Act of 2022, Division A (CHIPS Act of 2022) Issue: Support efforts to promote research integrity, address harassment in science, and address potential for foreign influence in science using a balanced approach, including stakeholder engagement from institutions of higher education. Support exemption of STEM graduates and health professionals from immigration caps. Issue: Consider strategies to prevent and address harassment in science and medicine Issue: Urge Congress to let science lead investigations of COVID-19 origins. Issue: Educate Congress on uses of gain of function research and prevent unreasonable restrictions. Issue: Support the use of a competitive peer review process for federal research grants and programs. Issue: Explore opportunities to improve research with cannabinoids. HR 869 / S 289, Research Investment to Spark the Economy Act Issue: Support research recovery at federal science agencies due to COVID-19 pandemic.

Client expense: $876,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office

Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries. Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act Support legislation aimed at accelerating medical research and patient access to novel therapeutics H.R. 6000 the Cures 2.0 Act

Client expense: $326,542 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures. S.236/H.R. 791, the Tracking COVID 19 Variants Act Issues related to genomic surveillance and sequencing H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021 H.R. 7152/S. 3534, the Tracking Pathogens Act the Advanced Research Projects Agency for Health (ARPA-H)

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

University-based scientific research and development Regional innovation DOE Office of Science Authorization Public Access Issues pertaining to artificial intelligence, machine learning high energy density physics, laser science and technologies, and quantum science and Inertial Fusion Energy. Planetary Defense / Near Earth Objects ARPA-H P.L. 115-368 - National Quantum Initiative Act of 2018 Securing American Science and Technology Act H.R. 5685 - The Securing American Leadership in Science and Technology Act HR 869, S. 289 - Research Investment to Spark the Economy (RISE) Act H.R. 2731 - Endless Frontiers Act America LEADS Act H.R. 476, S. 871 - Innovation Centers Acceleration Act H.R. 144, S. 627 - Supporting Early Career Researchers Act S.1260, U.S. Innovation and Competition Act H.R. 2225 - NSF for the Future Act H.R. 4588 - Regional Innovation Act of 2021 H.R. 4521, America Creating Opportunities for Manufacturing Pre-Eminence in Technology and Economic Strength (America COMPETES) Act of 2022 H.R.4346, P.L. 117-167 - Supreme Court Security Funding Act of 2022, CHIPS + Science Act

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.851/S.246 - Future Advancement of Academic Nursing (FAAN) Act H.R.9200 - Stop Nurse Shortages Act S.2114/H.R. 5699- Student Assisted Vaccination Effort (SAVE) Act H.R.8481/S. 3913-Improving DATA in Public Health Act H.R.8817/S.4844- National Nursing Workforce Center Act of 2022 H.R. 6087- Improving Access to Workers Compensation for Injured Federal Workers Act H.R. 7565- NIH IMPROVE Act H.R. 5721 VIPER Act S.4764/H.R.9040 - Reproductive Health Care Accessibility Act of 2022 H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.104/H.R.379 - Improving the Social Determinants of Health Act S.167/H.R.736 - Community Immunity During COVID-19 Act S.289/H.R.869- RISE Act S.346/H.R.959 - Black Maternal Health Momnibus Act of 2021 S.586/H.R. 3259 - NOPAIN Act S.1697/H.R.3352- Midwives for Maximizing Optimal Maternity Services (MOMS) Act H.R. 3337/S.1716- The Birth Access Benefiting Improved Essential Facility Services Act (BABIES) Act S.2235/H.R. 2067 - Medication Access and Training Expansion (MATE) Act S.1568/H.R.4407 - The Technical Reset to Advance the Instruction of Nurses (TRAIN) Act H.R. 8812/S.5212- Improving Care and Access to Nurses (I CAN) Act S.4182 - Workplace Violence Prevention for Health Care and Social Service Workers Act S.674- Public Health Infrastructure Saves Lives Act S.2187/H.R.4124- National Biomedical Research Act S.467/H.R.1324- Effective Suicide Screening and Assessment in the Emergency Department Act S.3799 - PREVENT Pandemics Act H.R. 831 - Health STATISTICS Act of 2021 H.R.1195 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 3550/S. 4905- Primary and Behavioral Health Care Access Act Support for clinical education, including graduate nursing education, and faculty Ensuring a Sustainable Public Health Workforce Title VIII Nursing Workforce Development Programs Nursing Education, Workforce, Research, and Public Health Infrastructure Needs Nursing faculty shortage Support Mental Health Programs for Nursing Students and the Workforce PPE, telehealth, mental health, and other resources and services to support Nursing Education, Practice, and the Workforce Safety and health of nurse educators and nursing students Public Health Emergency Waivers Ensure equity in COVID-19 efforts and health care Federal monkeypox response Comments on provider nondiscrimination Comments on the establishment of a National Directory of Healthcare Providers and Services

Client expense: $69,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Treasury, Dept of

FY 2022 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), and the Food & Drug Administration (FDA) S 289/HR 869 RISE Act - emergency funding for the NIH S 2187 - National Biomedical Research Act- establishes Biomedical Innovation Fund H.R. 5394- Meaningful Access to Federal Health Plan Claims Data Act of 2021 -ensures meaningful access to claims data by clinician-led clinical data registries HR 3773/S 1357- PACT Act of 2021- requires the NIH to support early career pediatric researchers

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.3062 HR 4502 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022; HR 710 Coronavirus Containment Corps Act; S289 RISE Act of 2021; HR 1268 Building COVID-19 Vaccine Confident Act of 2021; S.179 A bill to authorize the appropriation of an additional $10,000,000,000 to secure critical materials and supplies to combat the COVID-19 pandemic; S.783 COVID Community Care Act; H.R.8295,S.4659 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023.

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 869 and S. 289: Research Investment to Spark the Economy (RISE) Act of 2021 To authorize appropriations to offset costs resulting from reductions in research productivity in connection with the Coronavirus Disease 2019 (COVID-19), and for other purposes (ALL). H.R. 1160: Intelligence on Nefarious Foreign Leaders Using Education Networks for Corrupt Enrichment (INFLUENCE) Act To amend the Higher Education Act of 1965 to improve protections against foreign influence at institutions of higher education, and for other purposes (ALL). S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act A bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics (provisions relating to the creation of the Advanced Research Projects Agency-Health, university centers of excellence in advanced and continuous pharmaceutical manufacturing, pandemic preparedness university centers of excellence, and research at regional biocontainment labs). H.R. 5585: Advanced Research Project Agency-Health Act To establish the Advanced Research Projects Agency-Health, and for other purposes (ALL). H.R. 6000: Cures 2.0 Act To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes (provision relating to the creation of the Advanced Research Projects Agency-Health). H.R. 4369: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). S. 2589: Securing Americas Medicine Cabinet Act of 2021 A bill to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). H.R. 3851: Continuous Manufacturing Research Act of 2021 To improve support for research and development of advanced pharmaceutical manufacturing techniques and workforce (ALL). H.R. 5388 and S. 2740: Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production (ALL). H.R. 2617: Consolidated Appropriations Act, 2023 Making consolidated appropriations for the fiscal year ending September 30, 2023, and for providing emergency assistance for the situation in Ukraine, and for other purposes (provisions relating to university centers of excellence in advanced and continuous pharmaceutical manufacturing and the authorization of the Advanced Research Projects Agency-Health). Federal policy changes regarding fetal tissue research, biomedical research involving animals, research security, and facilities and administrative costs associated with research grants. White House and Executive Branch implementation of the CHIPS and Science Act.

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS P.L. 117-169: (H.R. 5376) INFLATION REDUCTION ACT OF 2022; PROVISIONS RELATING TO MEDICAID COVERAGE GAP, PART D OUT OF POCKET COSTS, AND EXTENDING THE ENHANCED PREMIUM TAX CREDITS H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS H.R. 6833: AFFORDABLE INSULIN NOW ACT; PROVISIONS RELATING TO FDA USER FEE REAUTHORIZATION S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2023 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS H.R. 5030: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS P.L. 117-169: (H.R. 5376) INFLATION REDUCTION ACT OF 2022; PROVISIONS RELATING TO MEDICAID COVERAGE GAP, PART D OUT OF POCKET COSTS, AND EXTENDING THE ENHANCED PREMIUM TAX CREDITS H.R. 5566: FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT OF 2021; ALL PROVISIONS H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS H.R. 6833: AFFORDABLE INSULIN NOW ACT; PROVISIONS RELATING TO FDA USER FEE REAUTHORIZATION S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS S. 2706: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2023 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 869 and S. 289: Research Investment to Spark the Economy (RISE) Act of 2021 To authorize appropriations to offset costs resulting from reductions in research productivity in connection with the Coronavirus Disease 2019 (COVID-19), and for other purposes (ALL). H.R. 1160: Intelligence on Nefarious Foreign Leaders Using Education Networks for Corrupt Enrichment (INFLUENCE) Act To amend the Higher Education Act of 1965 to improve protections against foreign influence at institutions of higher education, and for other purposes (ALL). S. 1260: United States Innovation and Competition Act of 2021 A bill to establish a new Directorate for Technology and Innovation in the National Science Foundation, to establish a regional technology hub program, to require a strategy and report on economic security, science, research, innovation, manufacturing, and job creation, to establish a critical supply chain resiliency program, and for other purposes (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education). H.R. 4521: America Creating Opportunities for Manufacturing, Pre-Eminence in Technology, and Economic Strength (COMPETES) Act of 2022 Vehicle for the Houses comprehensive innovation and competitiveness legislation (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education; immigration provisions relating to advanced degree holders from U.S. institutions of higher education; and provision relating to university centers of excellence in advanced and continuous pharmaceutical manufacturing). H.R. 4346: CHIPS and Science Act Vehicle for bipartisan legislation to support domestic semiconductor research and development and reauthorize major science agencies (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education). S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act A bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics (provisions relating to the creation of the Advanced Research Projects Agency-Health, university centers of excellence in advanced and continuous pharmaceutical manufacturing, pandemic preparedness university centers of excellence, and research at regional biocontainment labs). H.R. 5585: Advanced Research Project Agency-Health Act To establish the Advanced Research Projects Agency-Health, and for other purposes (ALL). H.R. 6000: Cures 2.0 Act To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes (provision relating to the creation of the Advanced Research Projects Agency-Health). H.R. 2225: National Science Foundation for the Future Act To authorize appropriations for fiscal years 2022, 2023, 2024, 2025, and 2026 for the National Science Foundation, and for other purposes (ALL). H.R. 3593: Department of Energy Science for the Future Act To provide guidance for and investment in the research and development activities of the Department of Energy Office of Science, and for other purposes (ALL). H.R. 4369: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). S. 2589: Securing Americas Medicine Cabinet Act of 2021 A bill to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). H.R. 3851: Continuous Manufacturing Research Act of 2021 To improve support for research and development of advanced pharmaceutical manufacturing techniques and workforce (ALL). H.R. 5388 and S. 2740: Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production (ALL). S. 4900 SBIR and STTR Extension Act of 2022 A bill to reauthorize the SBIR and STTR programs and pilot programs, and for other purposes (ALL). Federal policy changes regarding fetal tissue research, biomedical research involving animals, research security, and facilities and administrative costs associated with research grants. Pending federal legislation to enhance university climate research, service, and resiliency.

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

P.L. 111-148 Affordable Care Act, modifications Prior authorization utilization policies Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Medicare Physician Payment Reform Issues Medicare sequestration cuts Drug Pricing and Shortages Issues Medicare Part B Drug Price Issues Expansion of Telehealth Services Vision Research Funding Implementation of No Surprise Act HR 3173/S 3018, the Improving Seniors' Timely Access to Care Act HR 2163/S 464, Safe Step Act HR 1916/S 754, Ensuring Lasting Smiles Act Medicare Coverage for Low Vision Devices HR 4187, the Medicare Vision Act HR 869/S 289, Research Investment to Spark the Economy (RISE) Act HR 366, Protecting Access to Post-COVID 19 Telehealth Act HR3662, Patient Access to Urgent-Use Pharmacy Compounding Act of 2021 HR 3353, the Contact Lens Prescription Verification Modernization Act HR4122, Resident Education Deferred Interest (REDI) Act HR 5376, the Build Back Better Act HR 6000, Cures 2.0 Act S. 4333, the CLEAR Act S. 4348, Food and Drug Administration Safety & Landmark Advancements (FDASLA) Act

Client expense: $295,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 847/S. 224, Promoting Digital Privacy Technologies Act H.R. 869/S. 289, Research Investment to Spark the Economy (RISE) Act of 2021 H.R. 1251, Cyber Diplomacy Act of 2021 H.R. 1816, Information Transparency & Personal Data Control Act H.R. 2225, National Science Foundation for the Future Act H.R. 2501, Spectrum Coordination Act H.R. 2668/S. 1494, Consumer Protection and Recovery Act H.R. 3593, Department of Energy Science for the Future Act H.R. 3684, Infrastructure Investment and Jobs Act H.R. 3711, Safely Ensuring Lives Future Deployment and Research in Vehicle Evolution (SELF DRIVE) Act H.R. 3816, American Choice and Innovation Online Act H.R. 3826, Platform Competition and Opportunity Act of 2021 H.R. 3849, Augmenting Compatibility and Competition by Enabling Service Switching (ACCESS) Act of 2021 H.R. 4258, Improving Digital Identity Act of 2021 H.R. 4346, CHIPS and Science Act H.R. 4350, National Defense Authorization Act for Fiscal Year 2022 H.R. 4609, National Institute of Standards and Technology for the Future Act of 2021 H.R. 5315, Drone Infrastructure Inspection Grant Act H.R. 5367, Build Back Better Act, including provisions relating to Federal Trade Commission penalty and privacy provisions H.R. 5376, Inflation Reduction Act of 2022 H.R. 6416, Banning Surveillance Advertising Act of 2022 H.R. 6580/S. 3572, Algorithmic Accountability Act of 2022 H.R. 6796, Digital Services Oversight and Safety Act of 2022 H.R. 7624, Spectrum Innovation Act of 2022 H.R. 7900, National Defense Authorization Act for Fiscal Year 2023 H.R. 8152, American Data Privacy and Protection Act H.R. 8256/S. 4664, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2023 H.R. 8573/S.4676, Net Neutrality and Broadband Justice Act of 2022 S. 47, Adversarial Platform Prevention (APP) Act of 2021 S. 113, Balancing the Rights of Web Surfers Equally and Responsibly (BROWSER) Act of 2021 S. 919, Data Care Act of 2021 S. 1260, United States Innovation and Competition Act of 2021 S. 1494, Consumer Data Privacy and Security Act of 2021 S. 1957, State and Local Digital Service Act of 2021 S. 2710, Open App Markets Act S. 2992, American Innovation and Choice Online Act S. 3014, Next Generation Telecommunications Act S. 3035, Government Ownership and Oversight of Data in Artificial Intelligence (GOOD AI) Act of 2021 S. 3290, National MEP Supply Chain Database Act of 2021 S. 3330, Deceptive Experiences To Online Users Reduction (DETOUR) Act S. 3410, The Consumer Protection and Due Process Act S. 3663, Kids Online Safety Act S. 3890, Improving Intergovernmental Cooperation and Reducing Duplication Act of 2022 S. 4145, Consumer Protection Remedies Act of 2022 S. 4767, Proper Leadership to Align Networks for Broadband Act (PLAN) for Broadband Act Draft legislation titled FTC Procedural Reform Draft legislation on platform transparency Potential legislation related to the regulation of facial recognition technology Nomination of Laurie Locascio to be Under Secretary of Commerce for Standards and Technology Nominations of Bradley Merrill Thompson, Beena Ammanath, Christina Montgomery, Paul Daugherty, and Dr. Swani Sivasubramanian to serve on the National Artificial Intelligence Advisory Committee (NAIAC) Request for Comments on a Draft Memorandum to the Heads of Executive Departments and Agencies,Guidance for Regulation of Artificial Intelligence Applications (85 Fed. Reg. 1,825, January 13, 2020) Advanced Notice of Proposed Rulemaking, Federal Trade Commission; Deceptive or Unfair Earnings Claims (87 Fed. Reg. 13,951-13,958, March 11, 2022) Proposed Rule, Federal Trade Commission; Telemarketing Sales Rule (87 Fed. Reg. 33,677-33,695, June 3, 2022) Request for Extension of Time to File Comments, Federal Trade Commission; Advance Notice of Proposed Rulemaking for Trade Regulation Rule on Commercial Surveillance and Data Security (87 Fed. Reg. 51,273-51,299, August 22, 2022) Request for Information, White House Office of Science and Technology Policy and National Science Foundation; National AI Research Resource Interim Report (87 Fed. Reg. 31,914-31,915, May 25, 2022) Various issues relating to expanding access to high speed broadband internet service; broadband infrastructure and deployment; nominations at Federal Trade Commission (FTC), Federal Communications Commission (FCC), National Telecommunications and Information Administration (NTIA), and Office of Science and Technology Policy (OSTP); amendments related to American semiconductor capacity; broadband and economic relief; technology and economic relief; intermediary liability; potential federal privacy legislation; facial recognition technology; net neutrality; internet of things (IoT) devices; robocalls and the Telephone Consumer Protection Act (TCPA) (P.L. 102-243); implementation of the Childrens Online Privacy Protection Act (P.L. 105-277); implementation of the American Rescue Plan including provisions relating to the Technology Modernization Fund (P.L. 117-2); implementation of Clarifying Lawful Overseas Use of Data (CLOUD) Act (P.L. 115-141); implementation of the OPEN Government Data Act (P.L. 115-435); funding for implementation of the CHIPS for America Act, enacted as part of the FY2020 National Defense Authorization Act, (P.L. 116-92); implementation of the National Artificial Intelligence Act, enacted as part of the FY2021 National Defense Authorization Act (P.L. 116-283); implementation of the Drivers Privacy Protection Act (P.L. 103-322); implementation of the Infrastructure Investment and Jobs Act (P.L. 117-58); implementation of the Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science Act, (P.L. 117-167); appropriating funding for the Public Wireless Supply Chain Fund and the Multilateral Telecommunications Security Fund; increased technology modernization funding for FY22; FY2022 appropriations requests to the House and Senate Appropriations Committees subcommittees on Commerce, Justice, Science and Related Agencies, relating to Facial Recognition Vendor Testing (FRVT) and the National Institute of Standards and Technology (NIST); artificial intelligence; Executive Order 13859, Maintaining American Leadership in Artificial Intelligence; Executive Order 13984, Taking Additional Steps to Address the National Emergency with Respect to Significant Malicious Cyber-Enabled Activities; Executive Order 14017, Executive Order on America's Supply Chains; FTC hearings on Competition and Consumer Protection; Consumer Cybersecurity Labeling Pilots; Feedback to NIST on AI Risk Management: Future of the FCC Universal Service Fund; Federal Trade Commission (FTC) franchise rule; FTC enforcement; FTC section 13(b) and 19(b) enforcement; potential Executive Order on identity theft; Technology Modernization Fund in Financial Services and General Government proposed appropriations legislation; appropriations for the National Institute of Standards and Technology (NIST), Department of Energy, and the National Science Foundation (NSF); reauthorization for the National Institute of Standards and Technology (NIST); draft National Institute of Standards and Technology (NIST) guidance on Federal Internet of Things Device Cybersecurity; Security Criteria for Internet of Things (IoT) Devices; Draft Consumer Software Labeling Criteria; artificial intelligence regulation, standards, research and development; the Administrations Counter Unmanned Aircraft Systems (UAS) Action Plan

Client expense: $23,940,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), Natl Institute of Standards & Technology (NIST), Natl Science Foundation (NSF), Natl Telecommunications & Information Administration (NTIA), Office of Science & Technology Policy (OSTP), SENATE, Small Business Administration (SBA), Treasury, Dept of

Research Investment to Spark the Economy (RISE) Act (S.289/H.R.869) America Creating Opportunities for Manufacturing, Pre-Eminence in Technology, and Economic Strength Act of 2022 (America 'COMPETES' Act, H.R.4521) Endless Frontier Act / U.S. Innovation and Competition Act (S.1260/H.R.2731) Safeguarding American Innovation Act (S.1351) National Nuclear University Research Infrastructure Reinvestment Act (H.R.4819) National Science Foundation for the Future Act (H.R.2225) Department of Energy Science for the Future Act (H.R.3593) Cures 2.0 Act (H.R.6000) Microelectronics Research for Energy Innovation Act (H.R.6291/S.3740) Energizing Technology Transfer Act (H.R. 4606) Hydrogen Hubs (no specific bill) Small Business Innovation Research and Small Business Technology Transfer Improvements Act of 2021 (H.R.4033) American Data Privacy & Protection Act (H.R.8152) National R&D Strategy for Distributed Ledger Technology Act of 2022 (S.4109) National Defense Authorization Act for Fiscal Year 2023 (H.R.7900,S.4543 provision related to R&D) CHIPS and Science Act of 2022 (H.R.4346, now P.L 117-167) National Institute of Standards and Technology for the Future Act (H.R.4609) National R&D Strategy for Distributed Ledger Technology Act of 2022 (S.4109)

Client expense: $80,000 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Institute of Standards & Technology (NIST), Natl Oceanic & Atmospheric Administration (NOAA), Natl Science Foundation (NSF), Office of Science & Technology Policy (OSTP), SENATE, Transportation, Dept of (DOT)

Issue: Support reducing administrative and regulatory burden on scientists and research institutions. H.R. 4521, America COMPETES Act of 2022 S.1260, United States Innovation and Competition Act of 2021 Issue: Support efforts to promote research integrity, address harassment in science, and address potential for foreign influence in science using a balanced approach, including stakeholder engagement from institutions of higher education. Oppose Committee on Foreign Investment in the United States (CFIUS) review of proposed gifts and contracts to U.S. research institutions. Oppose excessively burdensome regulations on foreign gifts reporting. Support exemption of STEM graduates and health professionals from immigration caps. Issue: Urge Congress to let science lead investigations of COVID-19 origins. Issue: Educate Congress on uses of gain of function research and prevent unreasonable restrictions. Issue: Support the use of a competitive peer review process for federal research grants and programs. Issue: Explore opportunities to improve research with cannabinoids. HR 869 / S 289, Research Investment to Spark the Economy Act Issue: Support research recovery at federal science agencies due to COVID-19 pandemic. Issue: Support the nomination of Arati Prabhakar, PhD, to be the director of the Office of Science and Technology Policy.

Client expense: $912,077 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office

Issues related to biomedical research, basic science research, and reauthorization of 21st Century cures. S.236/H.R. 791, the Tracking COVID 19 Variants Act Issues related to genomic surveillance and sequencing H.R.869 / S.289, the Research Investment to Spark the Economy Act of 2021 H.R. 7152/S. 3534, the Tracking Pathogens Act the Advanced Research Projects Agency for Health (ARPA-H)

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 289/HR 869 - RISE Act (support) HR 2225 - National Science Foundation for the Future Act (support) HR 204 - STEM Opportunities Act (support) HR 144 - Supporting Early Career Researchers Act (support) HR 4521/S 1418 Bioeconomy Research & Development Act (support) HR 2471 - FY 2022 Consolidated Appropriations Act (support) S 1260 - United States Innovation and Competition Act (support) HR 4251 - America COMPETES Act (support) HR 5585 - ARPA H Act (support) S.3819 - ARPA-H Act (support) HR 6000 - Cures 2.0 Act (ARPA H section - support) Text of the Senate Amendment to the House Amendment to the Senate Amendment to H.R. 4346, Supreme Court Funding Act of 2022, became known as the CHIPS and Science Act (support - Division B, Titles I, II, III, V, and VI)

Client expense: $70,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Energy, Dept of, HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), SENATE, Veterans Affairs, Dept of (VA)

HR 2225 - National Science Foundation for the Future Act (support) S 289 HR 869 - RISE Act (support) H.R. 5376 - Inflation Reduction Act of 2022, Public Law No: 117-169 (support) Text of the Senate Amendment to the House Amendment to the Senate Amendment to H.R. 4346, Supreme Court Funding Act of 2022, became known as the CHIPS and Science Act (support - Division B, Titles I, II, III, V, and VI) HR 8294 - Transportation, Housing and Urban Development, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, and Veterans Affairs Appropriations Act, 2023 (support) HR 6833, the Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 (support) HR 4521/S 1418 Bioeconomy Research & Development Act (support) FY 2023 draft appropriations bills Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, HR 8239, S. 4461 (support) Commerce, Justice, Science, and Related Agencies, HR 8256, S. 4664 (support) Energy and Water Development, and Related Agencies, HR 8255, S. 4660 (support) Labor, Health and Human Services, Education, and Related Agencies, HR 8295, S. 4659 (support) Military Construction, Veterans Affairs, and Related Agencies, HR 8238, S. 4759 (support)

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.3062 HR 4502 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022; HR 710 Coronavirus Containment Corps Act; S289 RISE Act of 2021; HR 1268 Building COVID-19 Vaccine Confident Act of 2021; S.179 A bill to authorize the appropriation of an additional $10,000,000,000 to secure critical materials and supplies to combat the COVID-19 pandemic; S.783 COVID Community Care Act; HR2471 Consolidated Appropriations Act 2022; H.R.8295,S.4659 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023.

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries. Support Research through support of HR 869/S289 Research Investment to Spark the Economy (RISE) Act Support legislation aimed at accelerating medical research and patient access to novel therapeutics H.R. 6000 the Cures 2.0 Act

Client expense: $319,516 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 869/ S. 289: Research Investment to Spark the Economy (RISE) Act H.R. 8262, Interior and Environment Appropriations, 2023 H.R. 8295: Labor, Health, and Human Services, 2023 H.R. 8256/: Commerce, State, Justice, 2023 H.R. 8255: Energy-Water, 2022

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

FY 2022 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), and the Food & Drug Administration (FDA) S 289/HR 869 RISE Act - emergency funding for the NIH S 2187 - National Biomedical Research Act- establishes Biomedical Innovation Fund H.R. 5394- Meaningful Access to Federal Health Plan Claims Data Act of 2021 -ensures meaningful access to claims data by clinician-led clinical data registries HR 3773/S 1357- PACT Act of 2021- requires the NIH to support early career pediatric researchers

Client expense: $125,406 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

University-based scientific research and development Regional innovation DOE Office of Science Authorization Public Access Issues pertaining to artificial intelligence, machine learning high energy density physics, laser science and technologies, and quantum science and Inertial Fusion Energy. Planetary Defense / Near Earth Objects P.L. 115-368 - National Quantum Initiative Act of 2018 Securing American Science and Technology Act H.R. 5685 - The Securing American Leadership in Science and Technology Act HR 869, S. 289 - Research Investment to Spark the Economy (RISE) Act H.R. 2731 - Endless Frontiers Act America LEADS Act H.R. 476, S. 871 - Innovation Centers Acceleration Act H.R. 144, S. 627 - Supporting Early Career Researchers Act S.1260, U.S. Innovation and Competition Act H.R. 2225 - NSF for the Future Act H.R. 3593 - Department of Energy Science for the Future Act H.R. 4588 - Regional Innovation Act of 2021 H.R. 4521 - America Creating Opportunities for Manufacturing Pre-Eminence in Technology and Economic Strength (America COMPETES) Act of 2022 H.R.4346 - Supreme Court Security Funding Act of 2022

Client expense: $80,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Public health program funding Federal research funding Emergency funding for COVID therapeutics Research Investment to Spark the Economy (RISE) Act (H.R. 869/S. 289) Cures 2.0 Act (H.R. 6000) Advanced Research Projects Agency for Health (ARPA-H) FY 2023 NIH funding FY 2023 AHRQ funding FY 2023 CDC funding FY 2023 funding for CDC Sickle Cell Data Collection program FY 2023 funding for HRSA Sickle Cell Disease Treatment Demonstration program and Sickle Cell Disease Newborn Screening program Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023 (H.R. 8295/S. 4659) FY2023 Continuing Appropriations Act (through 12/16/2022) (H.R. 6833)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), President of the U.S., SENATE

Sickle cell disease/trait issues Hematology/oncology treatment issues Hematology/oncology drug research and approval issues General hematology public health and research issues Emergency funding for COVID therapeutics Research Investment to Spark the Economy (RISE) Act (H.R. 869/S. 289) Open access policy for peer reviewed research journals Issues impacting blood supply shortages/safety Issues related to convalescent plasma Issues impacting delivery of bone marrow, peripheral blood, and cord blood Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations COVID-19 vaccination policies/prioritization Clinical trials regulations and coverage Issues related to diversity, equity, and inclusion (DEI) in hematology research, practice, and training Cures 2.0 Act (H.R. 6000) Advanced Research Projects Agency for Health (ARPA-H) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706 / H.R. 5030) Meaningful Access to Federal Health Plan Claims Data Act (H.R. 5394) Health Equity and Accountability Act (H.R. 7585) Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 4128/S. 2209) Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act (S. 4348)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), President of the U.S., SENATE

H.R. 869/ S. 289: Research Investment to Spark the Economy (RISE) Act H.R. 5376, Build Back Better Act H.R. 4372, Interior and Environment Appropriations, 2022 H.R. 4502/S. 3062: Labor, Health, and Human Services, 2022 H.R. 4505/S. 3042: Commerce, State, Justice, 2022 H.R. 4549/S. 2605: Energy-Water, 2022

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.851/S.246 - Future Advancement of Academic Nursing (FAAN) Act S.2114/H.R. 5699- Student Assisted Vaccination Effort (SAVE) Act H.R.8481/S. 3913-Improving DATA in Public Health Act H.R.8817/S.4844- National Nursing Workforce Center Act of 2022 H.R. 6087- Improving Access to Workers Compensation for Injured Federal Workers Act H.R. 7565- NIH IMPROVE Act S.4764/H.R.9040 - Reproductive Health Care Accessibility Act of 2022 H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 S.104/H.R.379 - Improving the Social Determinants of Health Act S.167/H.R.736 - Community Immunity During COVID-19 Act S.289/H.R.869- RISE Act S.346/H.R.959 - Black Maternal Health Momnibus Act of 2021 S.586/H.R. 3259 - NOPAIN Act S.1697/H.R.3352- Midwives for Maximizing Optimal Maternity Services (MOMS) Act H.R. 3337- The Birth Access Benefiting Improved Essential Facility Services Act (BABIES) Act S.2235/H.R. 2067 - Medication Access and Training Expansion (MATE) Act S.1568/H.R.4407 - The Technical Reset to Advance the Instruction of Nurses (TRAIN) Act S.674- Public Health Infrastructure Saves Lives Act S.2187- National Biomedical Research Act S.467- Effective Suicide Screening and Assessment in the Emergency Department Act S.3799 - PREVENT Pandemics Act H.R. 831 - Health STATISTICS Act of 2021 H.R.1195 - Workplace Violence Prevention for Health Care and Social Service Workers Act H.R. 3550/S. 4905- Primary and Behavioral Health Care Access Act Support for clinical education, including graduate nursing education, and faculty Ensuring a Sustainable Public Health Workforce Title VIII Nursing Workforce Development Programs Nursing Education, Workforce, Research, and Public Health Infrastructure Needs Nursing faculty shortage Support Mental Health Programs for Nursing Students and the Workforce PPE, telehealth, mental health, and other resources and services to support Nursing Education, Practice, and the Workforce Safety and health of nurse educators and nursing students Public Health Emergency Waivers Ensure equity in COVID-19 efforts and health care Comments on new Rural Emergency Hospital (REH) designation and the removal of physician supervision requirements for APRN's at such facilities Comments on the CY 2023 Physician Fee Schedule Comments on Clinical Laboratory Improvement Amendments of 1988 Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories Comments on the Department of Health and Human Services Initiative to Strengthen Primary Health Care

Client expense: $69,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

The "Research Investment to Spark the Economy Act of 2021 (H.R. 869, S. 289)"; the "Resident Physician Shortage Reduction Act (S. 834, H.R. 2256); the "Build Back Better Act (H.R. 5376)";the "PREVENT Pandemics Act (S. 3799)"; the "VALID Act (S. 2209/H.R. 4128)", the "Food and Drug Amendments Act (H.R. 7667)"; the "Food and Drug Administration Safety and Landmark Advancements Act (S. 4348)" the "Bipartisan Safer Communities Act (S. 2938); the "Strengthening Mental Health Now Act (H.R. 7236)", the "Advancing Telehealth Beyond COVID-19 Act of 2022 (H.R. 4040)", the "FAIR Act (H.R. 8850)", and the "Continuing Appropriations and Ukraine Supplemental Appropriations act, 2023 (H.R. 6833)".

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issue: Support reducing administrative and regulatory burden on scientists and research institutions. H.R. 4521, America COMPETES Act of 2022 S.1260, United States Innovation and Competition Act of 2021 Issue: Support efforts to promote research integrity, address harassment in science, and address potential for foreign influence in science using a balanced approach, including stakeholder engagement from institutions of higher education. Oppose Committee on Foreign Investment in the United States (CFIUS) review of proposed gifts and contracts to U.S. research institutions. Oppose excessively burdensome regulations on foreign gifts reporting. Support exemption of STEM graduates and health professionals from immigration caps. Issue: Urge Congress to let science lead investigations of COVID-19 origins. Issue: Educate Congress on uses of gain of function research and prevent unreasonable restrictions. Issue: Support the use of a competitive peer review process for federal research grants and programs. Issue: Explore opportunities to improve research with cannabinoids. HR 869 / S 289, Research Investment to Spark the Economy Act Issue: Support research recovery at federal science agencies due to COVID-19 pandemic.

Client expense: $1,090,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, White House Office

Met with legislative staff to express support for biomedical research. Urged legislative staff to cosponsor the RISE Act (HR 869, S 289) to authorize supplemental funding to NIH to cover extraordinary COVID-19-related costs to biomedical research. Urged legislative staff to support a proposal to create and fund a COVID-19 and Pandemic Response Centers of Excellence program (HR 4292, S 2307). Urged legislative staff to support S 168/HR 708, the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act. Urged legislative staff to address telehealth provisions CMS identified as under Congress purview including audio-only visits and the ability for telehealth services to be provided to both new and established patients for acute and chronic conditions. Urged agency staff to create a dedicated fund within the provider relief fund to provide relief to faculty practice plans. Asked Representatives to consider legislation that makes changes to the regulation of laboratory testing (including the VALID Act) separately from the Medical Device User Fee Agreement (MDUFA) V legislative process.

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 869 and S. 289: Research Investment to Spark the Economy (RISE) Act of 2021 To authorize appropriations to offset costs resulting from reductions in research productivity in connection with the Coronavirus Disease 2019 (COVID-19), and for other purposes (ALL). H.R. 1160: Intelligence on Nefarious Foreign Leaders Using Education Networks for Corrupt Enrichment (INFLUENCE) Act To amend the Higher Education Act of 1965 to improve protections against foreign influence at institutions of higher education, and for other purposes (ALL). S. 1260: United States Innovation and Competition Act of 2021 A bill to establish a new Directorate for Technology and Innovation in the National Science Foundation, to establish a regional technology hub program, to require a strategy and report on economic security, science, research, innovation, manufacturing, and job creation, to establish a critical supply chain resiliency program, and for other purposes (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education). H.R. 4521: America Creating Opportunities for Manufacturing, Pre-Eminence in Technology, and Economic Strength (COMPETES) Act of 2022 Vehicle for the Houses comprehensive innovation and competitiveness legislation (provisions relating to funding for the National Science Foundation, NASA, and the Departments of Commerce and Energy; provisions on research and development and foreign gift/contract reporting at U.S. institutions of higher education; immigration provisions relating to advanced degree holders from U.S. institutions of higher education; and provision relating to university centers of excellence in advanced and continuous pharmaceutical manufacturing). S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats and (PREVENT) Pandemics Act A bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics (provisions relating to the creation of the Advanced Research Projects Agency-Health, university centers of excellence in advanced and continuous pharmaceutical manufacturing, pandemic preparedness university centers of excellence, and research at regional biocontainment labs). H.R. 5585: Advanced Research Project Agency-Health Act To establish the Advanced Research Projects Agency-Health, and for other purposes (ALL). H.R. 6000: Cures 2.0 Act To continue the acceleration of the discovery, development, and delivery of 21st century cures, and for other purposes (provision relating to the creation of the Advanced Research Projects Agency-Health). H.R. 2225: National Science Foundation for the Future Act To authorize appropriations for fiscal years 2022, 2023, 2024, 2025, and 2026 for the National Science Foundation, and for other purposes (ALL). H.R. 3593: Department of Energy Science for the Future Act To provide guidance for and investment in the research and development activities of the Department of Energy Office of Science, and for other purposes (ALL). H.R. 4369: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2021 To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). S. 2589: Securing Americas Medicine Cabinet Act of 2021 A bill to amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on advanced and continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes (ALL). H.R. 3851: Continuous Manufacturing Research Act of 2021 To improve support for research and development of advanced pharmaceutical manufacturing techniques and workforce (ALL). H.R. 5388 and S. 2740: Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act To establish a strategic active pharmaceutical ingredient reserve to maintain a domestic supply of active pharmaceutical ingredients and key starting materials needed for the manufacturing of essential generic medicines, and to build a pipeline for domestic active pharmaceutical ingredient production (ALL). Federal policy changes regarding fetal tissue research, biomedical research involving animals, research security, and facilities and administrative costs associated with research grants. Pending federal legislation to enhance university climate research, service, and resiliency.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2023 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). H.R. 8295, FY23 House Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding Senate consideration, FY23 Labor, Health and Human Services legislation - NIH, NCI, CDC DCPC, and OSH funding FY23 Funding for defense health research programs funded through the Congressionally Directed Military Research Programs (CDMRP) - lung cancer, overall funding Funding for the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles

Client expense: $940,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office

University-based scientific research and development Regional innovation DOE Office of Science Authorization Public Access Issues pertaining to artificial intelligence, machine learning high energy density physics, laser science and technologies, and quantum science and Inertial Fusion Energy. Planetary Defense / Near Earth Objects P.L. 115-368 - National Quantum Initiative Act of 2018 Securing American Science and Technology Act H.R. 5685 - The Securing American Leadership in Science and Technology Act HR 869, S. 289 - Research Investment to Spark the Economy (RISE) Act H.R. 2731 - Endless Frontiers Act America LEADS Act H.R. 476, S. 871 - Innovation Centers Acceleration Act H.R. 144, S. 627 - Supporting Early Career Researchers Act S.1260, U.S. Innovation and Competition Act H.R. 2225 - NSF for the Future Act H.R. 3593 - Department of Energy Science for the Future Act H.R. 4588 - Regional Innovation Act of 2021 H.R. 4521, America Creating Opportunities for Manufacturing Pre-Eminence in Technology and Economic Strength (America COMPETES) Act of 2022

Client expense: $60,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Sickle cell disease/trait issues Hematology/oncology treatment issues Hematology/oncology drug research and approval issues General hematology public health and research issues Emergency funding for COVID therapeutics Research Investment to Spark the Economy (RISE) Act (H.R. 869/S. 289) Open access policy for peer reviewed research journals Issues impacting blood supply shortages/safety Issues related to convalescent plasma Issues impacting delivery of bone marrow, peripheral blood, and cord blood Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations COVID-19 vaccination policies/prioritization Clinical trials regulations and coverage Issues related to diversity, equity, and inclusion (DEI) in hematology research, practice, and training Cures 2.0 Act (H.R. 6000) Advanced Research Projects Agency for Health (ARPA-H) Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act (S. 2706 / H.R. 5030) Meaningful Access to Federal Health Plan Claims Data Act (H.R. 5394) Health Equity and Accountability Act (H.R. 7585) Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 4128/S. 2209) Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act (S. 4348)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), President of the U.S., SENATE

Public health program funding Federal research funding Emergency funding for COVID therapeutics Research Investment to Spark the Economy (RISE) Act (H.R. 869/S. 289) Cures 2.0 Act (H.R. 6000) Advanced Research Projects Agency for Health (ARPA-H) FY 2023 NIH funding FY 2023 AHRQ funding FY 2023 CDC funding FY 2023 funding for CDC Sickle Cell Data Collection program FY 2023 funding for HRSA Sickle Cell Disease Treatment Demonstration program and Sickle Cell Disease Newborn Screening program Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023 (H.R. 8295)

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), President of the U.S., SENATE